Training and quality assurance for rectal cancer: 20 years of data is enough.
about
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerA pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team membersEffect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancerAbdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection marginMultidisciplinary Versus One-on-One Setting: A Qualitative Study of Clinicians' Perceptions of Their Relationship With Patients With Prostate CancerTechniques in total mesorectal excision surgeryIncidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.Can the results of anorectal (abdominoperineal) resection be improved: are circumferential resection margins too often positive?Contributing factors on lymph node yield after surgery for mid-low rectal cancerRole of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma.Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerEstablishing quality in colorectal surgery.Preoperative versus postoperative radiotherapy for rectal cancer in a decision analysis and outcome prediction model.Determinants of recurrence after intended curative resection for colorectal cancer.Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.Transanal total mesorectal excision.Intervention quality is not routinely assessed in Cochrane systematic reviews of radiation therapy interventions.Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer.Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions).Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.Extralevator versus standard abdominoperineal excision for rectal cancer.Anterior-entry abdominoperineal resection: a variation in the method of perineal dissection.Preoperative staging of rectal tumors: comparison of endorectal ultrasound, hydro-CT, and high-resolution endorectal MRI.Laparoscopic surgery for rectal cancerTransrectal ultrasonography and magnetic resonance imaging in the staging of rectal cancer. Effect of experienceHistopathological Analysis of 173 Consecutive Patients with Colorectal Carcinoma: A Pathologist's View
P2860
Q24200568-13E97595-EE43-4A04-9961-03E829A5B0F1Q24241258-6E656FBD-87C8-4527-A49C-2A10945BB066Q30495829-8C1709F4-E312-4F82-B4EE-DA0038960810Q33415864-55498B3F-25C7-47A5-8038-B5C0558B1C73Q33890616-8C62D77A-097A-49BC-A749-05462DAE1C4EQ33958747-94FAEBE9-2BBE-4026-BB9F-37017B3AA1B6Q34459761-602A562B-EB73-4639-B993-625A9F421B56Q35109120-5DA22F27-5BF2-414D-9659-43A11480A6EDQ35929343-2A3AE6EA-B1AA-403E-B5A9-05FA8EF0FC81Q36216917-4E3834EB-838B-45DD-806D-373B725FEA8BQ36391100-7F2833CC-8F03-405B-85F6-2D0ED1ABBC3FQ36620431-36ACC981-34B1-4FB1-8535-503D345F8BEBQ36769801-EFFE2D52-B67F-4C20-9538-5C1FCD229B55Q36791079-0F982D85-7F13-4B33-B3C7-E981848C8630Q37730979-180C334E-4800-4449-A189-FDBEB43CAA32Q37769272-426A8F05-7380-4DFC-8AA3-BCB748426040Q38024278-A7AF2970-442D-4332-9495-916DAD617A55Q38265049-F4C977C7-A157-469D-929E-C81F6123653FQ38452866-29381E1D-6403-42ED-B459-98B738B80435Q38562040-5E25AF7B-9D6B-4DA1-BADB-61F96700F42CQ38676468-940F257E-E96F-4044-94B4-B057592E2CB2Q39094676-309D1DB6-4772-41A6-9C46-1BB452DE158EQ47105028-022A36D7-2BFF-4E40-9CBF-DC587DCE632BQ48018828-324C38F3-95D3-4E1D-A6C2-16A3E6DDE1D0Q49564102-D2659997-47F2-41A0-9FC1-3C2DA57E4198Q51036451-AD7A5F7D-7C7C-44B9-8D6A-5B330C2326C1Q51423054-86B9C1CD-B524-410C-BB8A-BC1F37A3215DQ53415050-1BDA6A66-3B2E-4607-B1A2-1431B90EC63AQ57088804-18CEB0FF-AB64-481C-B540-E1C19FD90B09Q57778679-23789402-54D4-4A6D-AC66-0508DC43A10CQ58693800-827D13AB-FA09-4152-830C-D5E002D976F5
P2860
Training and quality assurance for rectal cancer: 20 years of data is enough.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Training and quality assurance for rectal cancer: 20 years of data is enough.
@ast
Training and quality assurance for rectal cancer: 20 years of data is enough.
@en
type
label
Training and quality assurance for rectal cancer: 20 years of data is enough.
@ast
Training and quality assurance for rectal cancer: 20 years of data is enough.
@en
prefLabel
Training and quality assurance for rectal cancer: 20 years of data is enough.
@ast
Training and quality assurance for rectal cancer: 20 years of data is enough.
@en
P1433
P1476
Training and quality assurance for rectal cancer: 20 years of data is enough.
@en
P2093
Phil Quirke
P304
P356
10.1016/S1470-2045(03)01248-8
P577
2003-11-01T00:00:00Z